{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:50:16Z","timestamp":1793217016508,"version":"4.5.0"},"reference-count":84,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Strokes are the main cause of death and long-term disability worldwide. A stroke is a heterogeneous multi-factorial condition, caused by a combination of environmental and genetic factors. Monogenic disorders account for about 1% to 5% of all stroke cases. The most common single-gene diseases connected with strokes are cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) Fabry disease, mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS) and a lot of single-gene diseases associated particularly with cerebral small-vessel disease, such as COL4A1 syndrome, cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), and Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). In this article the clinical phenotype for the most important single-gene disorders associated with strokes are presented. The monogenic causes of a stroke are rare, but early diagnosis is important in order to provide appropriate therapy when available.<\/jats:p>","DOI":"10.3390\/genes12121855","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:46:08Z","timestamp":1637721968000},"page":"1855","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Monogenic Causes of Strokes"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-4565","authenticated-orcid":false,"given":"Justyna","family":"Chojdak-\u0141ukasiewicz","sequence":"first","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Dziadkowiak","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Budrewicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1649503","article-title":"Global Burden of Stroke","volume":"38","author":"Katan","year":"2018","journal-title":"Semin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/brain\/123.9.1784","article-title":"Genetics and ischaemic stroke","volume":"123","author":"Hassan","year":"2000","journal-title":"Brain"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Seshadri, S., and Debette, S. (2016). Monogenic Diseases Causing Cerebrovascular Disease and Stroke. Risk Factors for Cerebrovascular Disease and Stroke, Oxford University Press. Available online: http:\/\/oxfordmedicine.com\/view\/10.1093\/med\/9780199895847.001.0001\/med-9780199895847-chapter-3.","DOI":"10.1093\/med\/9780199895847.001.0001"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12031-019-01313-z","article-title":"CADASIL with Atypical Clinical Symptoms, Magnetic Resonance Imaging, and Novel Mutations: Two Case Reports and a Review of the Literature","volume":"68","author":"Sari","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"105410","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105410","article-title":"A Novel Mutation Outside of the EGFr Encoding Exons of NOTCH3 Gene in a Chinese with CADASIL","volume":"29","author":"Wang","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/STROKEAHA.118.021560","article-title":"Role of NOTCH3 Mutations in the Cerebral Small Vessel Disease Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy","volume":"49","author":"Coupland","year":"2018","journal-title":"Stroke"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1440-1789.2011.01290.x","article-title":"Pericytes as a new target for pathological processes in CADASIL","volume":"32","author":"Dziewulska","year":"2012","journal-title":"Neuropathology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1177\/0271678X17690164","article-title":"Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI","volume":"38","author":"Vignaud","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12975-019-00742-7","article-title":"Progression and Classification of Granular Osmiophilic Material (GOM) Deposits in Functionally Characterized Human NOTCH3 Transgenic Mice","volume":"11","author":"Gravesteijn","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.008","article-title":"Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL): From Discovery to Gene Identification","volume":"20","author":"Fukutake","year":"2011","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000117096","article-title":"Familial Young-Adult-Onset Arteriosclerotic Leukoencephalopathy with Alopecia and Lumbago without Arterial Hypertension","volume":"35","author":"Fukutake","year":"1995","journal-title":"Eur. Neurol."},{"key":"ref_13","unstructured":"Onodera, O., Nozaki, H., and Fukutake, T. (2019, November 07). HTRA1 Disorder. GeneReviews\u00ae 2010, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK32533\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16496","DOI":"10.1073\/pnas.1418087111","article-title":"Cerebral small vessel disease-related protease HtrA1 processes latent TGF-\u03b2 binding protein 1 and facilitates TGF-\u03b2 signaling","volume":"111","author":"Beaufort","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/0100-3984.2018.0117","article-title":"Differential diagnosis of temporal lobe lesions with hyperintense signal on T2-weighted and FLAIR sequences: Pictorial essay","volume":"53","author":"Santana","year":"2020","journal-title":"Radiol. Bras."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fneur.2020.00545","article-title":"HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature","volume":"11","author":"Uemura","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/brain\/aww217","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"139","author":"Stam","year":"2016","journal-title":"Brain"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1918","DOI":"10.1212\/WNL.0000000000010659","article-title":"Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy","volume":"95","author":"Ford","year":"2020","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10875-018-0584-x","article-title":"TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia","volume":"39","author":"Paradis","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","article-title":"Human Disease Phenotypes Associated with Mutations in TREX1","volume":"35","author":"Rice","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jnen\/nly115","article-title":"Retinal Vasculopathy with Cerebral Leukodystrophy: Clinicopathologic Features of an Autopsied Patient with a Heterozygous TREX 1 Mutation","volume":"78","author":"Saito","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/0271678X20929430","article-title":"Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"41","author":"Hoogeveen","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-021-02250-4","article-title":"Serial magnetic resonance imaging changes of pseudotumor lesions in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: A case report","volume":"21","author":"Yan","year":"2021","journal-title":"BMC Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1161\/STROKEAHA.117.018556","article-title":"Circulating Endothelial Markers in Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations","volume":"48","author":"Pelzer","year":"2017","journal-title":"Stroke"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1423","DOI":"10.1212\/WNL.0000000000006329","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy (RVCL): A rare mimic of tumefactive MS","volume":"91","author":"Raynowska","year":"2018","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-01818-w","article-title":"Late-onset MELAS syndrome with mtDNA 14453G\u2192A mutation masquerading as an acute encephalitis: A case report","volume":"20","author":"Yokota","year":"2020","journal-title":"BMC Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jmedgenet-2012-101159","article-title":"Complex I deficiency: Clinical features, biochemistry and molecular genetics","volume":"49","author":"Fassone","year":"2012","journal-title":"J. Med Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.ejhg.5200712","article-title":"An mtDNA mutation, 14453G\u2192A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome","volume":"9","author":"Ravn","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.56.3.405","article-title":"Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation","volume":"56","author":"Bataillard","year":"2001","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s00415-020-10390-9","article-title":"Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome","volume":"268","author":"Chakrabarty","year":"2021","journal-title":"J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/acn3.532","article-title":"Phenotypic heterogeneity in m.3243A>G mitochon-drial disease: The role of nuclear factors","volume":"5","author":"Pickett","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.tig.2020.06.009","article-title":"Mitochondrial Diseases: A Diagnostic Revolution","volume":"36","author":"Schon","year":"2020","journal-title":"Trends Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2019.00412","article-title":"New Variant of MELAS Syndrome With Executive Dysfunc-tion, Heteroplasmic Point Mutation in the MT-ND4 Gene (m.12015T>C; p.Leu419Pro) and Comorbid Polyglandular Auto-immune Syndrome Type 2","volume":"10","author":"Endres","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rodan, L.H., Poublanc, J., Fisher, J.A., Sobczyk, O., Mikulis, D.J., and Tein, I. (2020). L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238224"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.radcr.2016.09.003","article-title":"Migratory stroke-like lesions in a case of adult-onset mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome and a review of imaging findings","volume":"11","author":"Cai","year":"2016","journal-title":"Radiol. Case Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.braindev.2008.01.003","article-title":"Serial brain imaging analysis of stroke-like episodes in ME-LAS","volume":"30","author":"Ito","year":"2008","journal-title":"Brain Dev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.braindev.2010.06.010","article-title":"Neuroimaging of stroke-like episodes in MELAS","volume":"33","author":"Ito","year":"2011","journal-title":"Brain Dev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2010.05624.x","article-title":"MELAS and l-arginine therapy: Pathophysiology of stroke-like episodes","volume":"1201","author":"Koga","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3174\/ajnr.A6325","article-title":"Acute Cortical Lesions in MELAS Syndrome: Anatomic Distribution, Symmetry, and Evolution","volume":"41","author":"Bhatia","year":"2019","journal-title":"Am. J. Neuroradiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00234-003-1029-6","article-title":"Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema","volume":"45","author":"Wang","year":"2003","journal-title":"Neuroradiology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00415-019-09283-3","article-title":"A cluster of disseminated small cortical lesions in ME-LAS: Its distinctive clinical and neuroimaging features","volume":"266","author":"Hongo","year":"2019","journal-title":"J. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.wno.0000249317.81367.3d","article-title":"Evolution of Brain Imaging Abnormalities in Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes","volume":"26","author":"Bi","year":"2006","journal-title":"J. NeuroOphthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/RCT.0000000000000712","article-title":"Conventional and Diffusional Magnetic Resonance Imaging Features of Mitochon-drial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes in Chinese Patients: A Study of 40 Cases","volume":"42","author":"Xu","year":"2018","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3348\/kjr.2011.12.1.15","article-title":"Diffusion and Perfusion Characteristics of MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episode) in Thirteen Patients","volume":"12","author":"Kim","year":"2011","journal-title":"Korean J. Radiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2169\/internalmedicine.52.0188","article-title":"MELAS and Reversible Vasoconstriction of the Major Cerebral Arteries","volume":"52","author":"Yoshida","year":"2013","journal-title":"Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ferrer, I., and Vidal, N. (2018). Neuropathology of cerebrovascular diseases. Handbook of Clinical Neurology, Elsevier. Available online: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128023952000079.","DOI":"10.1016\/B978-0-12-802395-2.00007-9"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1440-1789.2009.01026.x","article-title":"MELAS with diffuse degeneration of the cerebral white matter: Report of an autopsy case","volume":"30","author":"Yokoyama","year":"2010","journal-title":"Neuropathology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.12659\/PJR.884010","article-title":"CT and MRI imaging of the brain in MELAS syndrome","volume":"78","author":"Walecka","year":"2013","journal-title":"Pol. J. Radiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2015-09-618587","article-title":"Genetic treatment of a molecular disorder: Gene therapy approaches to sickle cell disease","volume":"127","author":"Hoban","year":"2016","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Inusa, B., Hsu, L., Kohli, N., Patel, A., Ominu-Evbota, K., Anie, K.A., and Atoyebi, W. (2019). Sickle Cell Disease\u2014Genetics, Pathophysiology, Clinical Presentation and Treatment. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5020020"},{"key":"ref_51","first-page":"213","article-title":"Stroke in sickle cell disease: Demographic, clinical, and therapeutic considerations","volume":"28","year":"1991","journal-title":"Semin. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(06)70469-0","article-title":"Pathophysiology and treatment of stroke in sickle-cell disease: Present and fu-ture","volume":"5","author":"Switzer","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Strouse, J. (2016). Sickle cell disease. Handbook of Clinical Neurology, Elsevier. Available online: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128029732000185.","DOI":"10.1016\/B978-0-12-802973-2.00018-5"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3101(24)00141-5","article-title":"Neurologic complications of sickle cell disease","volume":"36","author":"Pavlakis","year":"1989","journal-title":"Adv. Pediatr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.surneu.2008.03.044","article-title":"Intracranial aneurysms in sickle cell patients: Report of 2 cases and review of the literature","volume":"72","author":"Reis","year":"2009","journal-title":"Surg. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM200003093421001","article-title":"Clinical and Genetic Features of Ehlers\u2013Danlos Syndrome Type IV, the Vascular Type","volume":"342","author":"Pepin","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jvs.2005.03.053","article-title":"The spectrum, management and clinical out-come of Ehlers-Danlos syndrome type IV: A 30-year experience","volume":"42","author":"Oderich","year":"2005","journal-title":"J. Vasc. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-2-32","article-title":"Ehlers-Danlos syndrome type IV","volume":"2","author":"Germain","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jns.2012.04.005","article-title":"Multiple strokes and bilateral carotid dissections: A fulminant case of newly diagnosed Ehlers\u2013Danlos Syndrome Type IV","volume":"318","author":"Dohle","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ana.410380620","article-title":"Cerebrovascular complications in Ehlers-Danlos syndrome type IV","volume":"38","author":"North","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_61","unstructured":"Scriver, C.R., Sly, W.S., Childs, B., Beaudet, A.L., and Valle, D. (1995). Disorders of transsulfuration. The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill. [7th ed.]."},{"key":"ref_62","unstructured":"Femandes, J., Saudubary, J.M., and Van den Berghe, G. (1996). Homocystinuria due to cystathionine beta-synthase deficiency and related disorders. Inborn Metabolic Diseases Diagnosis and Treatment, Springer. [2nd ed.]."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1469-8749.1999.tb00566.x","article-title":"Fatal haemorrhagic infarct in an infant with homo-cystinuria","volume":"41","author":"Cardo","year":"1999","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.matbio.2013.06.003","article-title":"Ectopic mineralization disorders of the extracellular matrix of connective tissue: Molecular genetics and pathomechanisms of aberrant calcification","volume":"33","author":"Li","year":"2013","journal-title":"Matrix Biol."},{"key":"ref_65","first-page":"4","article-title":"The vascular phenotype in Pseudoxanthoma elasticum and related disorders: Contribution of a genetic disease to the understanding of vascular calcification","volume":"4","author":"Omarjee","year":"2013","journal-title":"Front. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural History of Fabry Renal Disease: Influence of \u03b1-Galactosidase A Activity and Genetic Mutations on Clinical Course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry Disease Frequently Occurs Before Diagnosis and in the Absence of Other Clinical Events: Natural History Data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0035-3787(06)75051-2","article-title":"Manifestations neurologiques de la maladie de Fab-ry","volume":"162","author":"Clavelou","year":"2006","journal-title":"Rev. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan\u2019s syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J. Med Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.21037\/acs.2017.10.03","article-title":"Aortic dissection in patients with Marfan syndrome based on the IRAD data","volume":"6","author":"Trimarchi","year":"2017","journal-title":"Ann. Cardiothorac. Surg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.STR.25.4.889","article-title":"Neurovascular manifestations of heritable connective tissue disorders. A review","volume":"25","author":"Schievink","year":"1994","journal-title":"Stroke"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/hs0302.103816","article-title":"Neurovascular Complications of Marfan Syndrome: A Retrospective, Hospital-Based Study","volume":"33","author":"Wityk","year":"2002","journal-title":"Stroke"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/gim.2014.210","article-title":"The expanding phenotype of COL4A1 and COL4A2 mutations: Clinical data on 13 newly identified families and a review of the literature","volume":"17","author":"Meuwissen","year":"2015","journal-title":"Genet. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa053727","article-title":"Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke","volume":"354","author":"Gould","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ejhg.2011.155","article-title":"Cerebral cavernous malformations: From molecular pathogenesis to ge-netic counselling and clinical management","volume":"20","author":"Haasdijk","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"El-Koussy, M., Stepper, F., Spreng, A., Lukes, A., Gralla, J., Brekenfeld, C., Sturzenegger, M., and Schroth, G. (2011). Incidence, clinical presentation and imaging findings of cavernous malformations of the CNS. A twenty-year experience. Swiss Med. Wkly., 141.","DOI":"10.4414\/smw.2011.13172"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"32279","DOI":"10.18632\/oncotarget.5443","article-title":"The cerebral cavernous malformations proteins","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Lanfranconi, S., Piergallini, L., Ronchi, D., Valcamonica, G., Conte, G., Marazzi, E., Manenti, G., Bertani, G.A., Locatelli, M., and Triulzi, F. (2021). Clinical, neuroradiological and genetic findings in a cohort of patients with multiple Cerebral Cavernous Malformations. Metab. Brain Dis., 1\u20138.","DOI":"10.1007\/s11011-021-00809-1"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/jnnp-2012-303898","article-title":"Genetics of cerebral amyloid an-giopathy: Systematic review and meta-analysis","volume":"84","author":"Rannikmae","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1750-3639.1996.tb00793.x","article-title":"Hereditary Cerebral Hemorrhage with Amyloido-sis-Dutch Type (HCHWA-D): I\u2014A Review of Clinical, Radiologic and Genetic Aspects","volume":"6","author":"Bornebroek","year":"1996","journal-title":"Brain Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.2741\/2941","article-title":"Involvement of cystatin C in pathophysiology of CNS diseases","volume":"13","author":"Nagai","year":"2008","journal-title":"Front. Biosci."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/12\/1855\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:34:48Z","timestamp":1760168088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/12\/1855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["genes12121855"],"URL":"https:\/\/doi.org\/10.3390\/genes12121855","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}